We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$3B
AUM Growth
-$844M
Cap. Flow
-$1.01B
Cap. Flow %
-33.73%
Top 10 Hldgs %
26.42%
Holding
246
New
68
Increased
28
Reduced
60
Closed
83

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$76.1M
2
PFE icon
Pfizer
PFE
+$68.2M
3
HON icon
Honeywell
HON
+$47.8M
4
FWONA icon
Liberty Media Series A
FWONA
+$43.6M
5
MEOH icon
Methanex
MEOH
+$41.5M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$154M
2
SIG icon
Signet Jewelers
SIG
+$71.5M
3
IP icon
International Paper
IP
+$64M
4
DIS icon
Walt Disney
DIS
+$62.5M
5
MHK icon
Mohawk Industries
MHK
+$58M

Sector Composition

Rank Sector Weight
1 Financials 13.62%
2 Technology 12.79%
3 Communication Services 12.02%
4 Industrials 11.66%
5 Healthcare 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CX icon
151
Cemex
CX
$17.4B
$1.47M 0.05%
125,175
-1,384,427
-92% -$15.7M
WCN
152
Waste Connections
WCN
$42.7B
$1.11M 0.04%
34,199
-265,801
-89% -$7.99M
ZBH icon
153
Zimmer Biomet
ZBH
$17.6B
$1.04M 0.03%
+10,300
New +$1M
WFM
154
DELISTED
Whole Foods Market Inc
WFM
$967K 0.03%
+25,000
New +$1.09M
IPXL
155
DELISTED
Impax Laboratories, Inc.
IPXL
$750K 0.03%
25,000
-81,132
-76% -$2.19M
MNTA
156
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$725K 0.02%
60,000
-37,400
-38% -$442K
AVDL
157
DELISTED
Avadel Pharmaceuticals
AVDL
$219K 0.01%
14,600
-4,551
-24% -$54.9K
AGCO icon
158
AGCO
AGCO
$8.69B
-100,000
Closed -$5.52M
AIG icon
159
American International
AIG
$41.7B
-301,841
Closed -$15.1M
ALB icon
160
Albemarle
ALB
$13.6B
-133,600
Closed -$8.88M
AMP icon
161
Ameriprise Financial
AMP
$46.4B
-107,041
Closed -$11.8M
AMRN
162
Amarin Corp
AMRN
$285M
-18,767
Closed -$679K
AWI icon
163
Armstrong World Industries
AWI
$6.86B
-600,000
Closed -$31.9M
AWK icon
164
American Water Works
AWK
$26.3B
-540,517
Closed -$24.5M
BAX icon
165
Baxter International
BAX
$11.6B
-92,050
Closed -$3.68M
BIIB icon
166
Biogen
BIIB
$29.8B
-10,010
Closed -$3.06M
BKNG icon
167
Booking.com
BKNG
$138B
-950,000
Closed -$45.3M
BLUE
168
DELISTED
bluebird bio
BLUE
-4,636
Closed -$1.37M
BRO icon
169
Brown & Brown
BRO
$22.8B
-549,850
Closed -$8.46M
BURL icon
170
Burlington
BURL
$22B
-225,000
Closed -$6.64M
CCK icon
171
Crown Holdings
CCK
$12.8B
-443,524
Closed -$19.8M
CIB icon
172
Grupo Cibest SA
CIB
$20.6B
-214,698
Closed -$12.1M
CMP icon
173
Compass Minerals
CMP
$1.24B
-15,014
Closed -$1.24M
CNMD icon
174
CONMED
CNMD
$1.3B
-117,100
Closed -$5.09M
COF icon
175
Capital One
COF
$124B
-193,375
Closed -$14.9M

Similar funds

Ascend Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Ascend Capital held 246 positions worth $3B, down 22% from $3.85B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ascend Capital withdrew a net $1.01B in Q2 2014, closing 83 positions and reducing 60 holdings. Its most notable exit was Verizon, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Ascend Capital opened a new position in Pfizer worth $67.4M.

  • Ascend Capital's largest Q2 2014 buy was Pfizer: 2,391,995 shares worth $67.4M.
  • Ascend Capital added most to RTX Corp in Q2 2014, an estimated $76.1M increase.
  • Ascend Capital's biggest Q2 2014 reduction was International Paper, cutting an estimated $64M.
  • Ascend Capital fully exited Verizon in Q2 2014, selling an estimated $154M.
  • Ascend Capital's ten largest holdings make up 26% of its $3B portfolio in Q2 2014.
  • Ascend Capital opened 68 new positions and closed 83 in Q2 2014.
  • Ascend Capital's portfolio value fell 22% quarter-over-quarter to $3B.

Based on Ascend Capital's 13F filing for Q2 2014, filed 13 Aug 2014.